mono – Traduction – Dictionnaire Keybot

Spacer TTN Translation Network TTN TTN Login Deutsch English Spacer Help
Langues sources Langues cibles
Keybot 15 Résultats  ar2006.emcdda.europa.eu
  Bibliography  
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), pp. 196–8.
Van den Brink, W. (2005), «Epidemiology of cocaine and crack: implications for drug policy and treatment», Sucht 51(4), pp. 196–8.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment“, Sucht 51(4), S. 196-198.
Van den Brink, W. (2005), «Epidemiology of cocaine and crack: implications for drug policy and treatment», Sucht 51(4), pp. 196-198.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), pagg. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), σσ. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), blz. 196-198.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment“, Sucht 51(4), str. 196–198.
Van den Brink, W. (2005): "Epidemiology of cocaine and crack: implications for drug policy and treatment", Sucht 51(4), s. 196–198.
Van den Brink, W. (2005), ”Epidemiology of cocaine and crack: implications for drug policy and treatment”, Sucht vol. 51 (4), s. 196–198.
Van den Brink, W. (2005), „Epidemiology of cocaine and crack: implications for drug policy and treatment”, Sucht 51(4), 196–8. o.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s. 196-8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s 196 –8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), str. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s. 196–8.
Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), ss. 196–8.
  Bibliography  
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, pp. 203–11.
Shearer, J. et Gowing, L.R. (2004), «Pharmacotherapies for problematic psychostimulant use: a review of current research», Drug and alcohol review 23, pp. 203–11.
Shearer, J. und Gowing, L. R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research“, Drug and alcohol review 23, S. 203-211.
Shearer, J. and Gowing, L.R. (2004), «Pharmacotherapies for problematic psychostimulant use: a review of current research», Drug and alcohol review 23, pp. 203-211.
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, pagg. 203–11.
Shearer, J. και Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, σσ. 203–11.
Shearer, J. en Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, blz. 203-211.
Shearer, J. and Gowing, L.R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research“, Drug and alcohol review 23, str. 203–211.
Shearer, J. og Gowing, L.R. (2004): "Pharmacotherapies for problematic psychostimulant use: a review of current research", Drug and alcohol review 23, s. 203–211.
Shearer, J. ja Gowing, L.R. (2004), ”Pharmacotherapies for problematic psychostimulant use: a review of current research”, Drug and alcohol review vol. 23, s. 203–211.
Shearer, J. és Gowing, L.R. (2004), „Pharmacotherapies for problematic psychostimulant use: a review of current research”, Drug and alcohol review 23, 203–11. o.
Shearer, J. og Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203-11.
Shearer, J. a Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203 – 11.
Shearer, J. in Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, str. 203–11.
Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203–11.
Shearer, J. ve Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, ss. 203–11.
  Bibliography  
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, pp. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), «Community reinforcement therapy for cocaine-dependent outpatients», Archives of general psychiatry 60, pp. 1043–52.
Higgins, S. T., Sigmon, S. C., Wong, C. J. et al. (2003), „Community reinforcement therapy for cocaine-dependent outpatients“, Archives of general psychiatry 60, S. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), «Community reinforcement therapy for cocaine-dependent outpatients», Archives of general psychiatry 60, pp. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. e altri (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, pagg. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. κ.ά. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, σσ. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, blz. 1043-1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. a kol. (2003), „Community reinforcement therapy for cocaine-dependent outpatients“, Archives of general psychiatry 60, str. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. m.fl. (2003): "Community reinforcement therapy for cocaine-dependent outpatients", Archives of general psychiatry 60, s. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ”Community reinforcement therapy for cocaine-dependent outpatients”, Archives of general psychiatry vol. 60, s. 1043–1052.
Higgins, S.T., Sigmon, S.C., Wong, C.J. és mások (2003), „Community reinforcement therapy for cocaine-dependent outpatients”, Archives of general psychiatry 60, 1043–52. o.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. a kol. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043 – 52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, str. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043–52.
Higgins, S.T., Sigmon, S.C., Wong, C.J. vd. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, ss. 1043–52.
  Bibliography  
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, pp. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), «Effectiveness of drug dependence treatment in HIV prevention», International journal of drug policy 16S, pp. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), „Effectiveness of drug dependence treatment in HIV prevention“, International journal of drug policy 16S, S. S67-S75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), «Effectiveness of drug dependence treatment in HIV prevention», International journal of drug policy 16S, pp. S67-75.
Farrell, M., Gowing, L., Marsden, J. e altri (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, pagg. S67–75.
Farrell, M., Gowing, L., Marsden, J. κ.ά. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, σσ. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), ‘Effectiveness of drug dependence treatment in HIV prevention’, International journal of drug policy 16S, blz. S67-75.
Farrell, M., Gowing, L., Marsden, J. a kol. (2005), „Effectiveness of drug dependence treatment in HIV prevention“, International journal of drug policy 16S, str. S67–75.
Farrell, M., Gowing, L., Marsden, J. m.fl. (2005): "Effectiveness of drug dependence treatment in HIV prevention", International journal of drug policy 16S, s. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), ”Effectiveness of drug dependence treatment in HIV prevention”, International journal of drug policy vol. 16S, s. 67–75.
Farrell, M., Gowing, L., Marsden, J. és mások (2005), „Effectiveness of drug dependence treatment in HIV prevention”, International journal of drug policy 16S, S67–75. o.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67-75.
Farrell, M., Gowing, L., Marsden, J. a kol. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67 – 75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, str. S67–75.
Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67–75.
Farrell, M., Gowing, L., Marsden, J. vd. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, ss. S67–75.
  Bibliography  
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), pp. 85–99.
Roe, E. et Becker, J (2005), «Drug prevention with vulnerable young people: a review», Drugs: education, prevention and policy, 12(2), pp. 85–99.
Roe, E. und Becker, J. (2005), „Drug prevention with vulnerable young people: a review“, Drugs: education, prevention and policy, 12(2), S. 85-99.
Roe, E. y Becker, J (2005), «Drug prevention with vulnerable young people: a review», Drugs: education, prevention and policy, 12(2), pp. 85-99.
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), pagg. 85–99.
Roe, E. και Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), σσ. 85–99.
Roe, E. en Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), blz. 85-99.
Roe, E. and Becker, J (2005), „Drug prevention with vulnerable young people: a review“, Drugs: education, prevention and policy, 12(2), str. 85–99.
Roe, E. og Becker, J (2005): "Drug prevention with vulnerable young people: a review", Drugs: education, prevention and policy, 12(2), s. 85–99.
Roe, E. ja Becker, J (2005), ”Drug prevention with vulnerable young people: a review”, Drugs: education, prevention and policy, vol. 12 (2), s. 85–99.
Roe, E. és Becker, J (2005), „Drug prevention with vulnerable young people: a review”, Drugs: education, prevention and policy, 12(2), 85–99. o.
Roe, E. og Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85-99.
Roe, E. a Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85 – 99.
Roe, E. in Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), str. 85–99.
Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85–99.
Roe, E. ve Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), ss. 85–99.
  Bibliography  
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), pp. 321–3.
Bossong, M.G., Van Dijk, J.P. et Niesink, R.J.M. (2005), «Methylone and mCPP, two new drugs of abuse?», Addiction biology 10(4), pp. 321–3.
Bossong, M. G., Van Dijk, J. P. und Niesink, R. J. M. (2005), „Methylone and mCPP, two new drugs of abuse?“, Addiction biology 10(4), S. 321-323.
Bossong, M.G., Van Dijk, J.P. y Niesink, R.J.M. (2005), «Methylone and mCPP, two new drugs of abuse?», Addiction biology 10(4), pp. 321-3.
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), pagg. 321–3.
Bossong, M.G., Van Dijk, J.P. και Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), σσ. 321–3.
Bossong, M.G., Van Dijk, J.P. en Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), blz. 321-323.
Bossong, M.G., Van Dijk, J.P. a Niesink, R.J.M. (2005), „Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), str. 321–323.
Bossong, M.G., Van Dijk, J.P. og Niesink, R.J.M. (2005): "Methylone and mCPP, two new drugs of abuse?", Addiction biology 10(4), s. 321–323.
Bossong, M.G., Van Dijk, J.P. ja Niesink, R.J.M. (2005), ”Methylone and mCPP, two new drugs of abuse?”, Addiction biology vol. 10 (4), s. 321–323.
Bossong, M.G., Van Dijk, J.P. és Niesink, R.J.M. (2005), „Methylone and mCPP, two new drugs of abuse?”, Addiction biology 10(4), 321–3. o.
Bossong, M.G., Van Dijk, J.P. og Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. a Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. in Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), str. 321–3.
Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.
Bossong, M.G., Van Dijk, J.P. ve Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), ss. 321–3.
  Bibliography  
  Chapter 1: Policies and...  
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, pp.147–55.
Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), «Cocaine use in Europe – a multi-centre study: patterns of use in different groups», European addiction research 10, pp.147–55.

(6) Council Directive 91/308/EEC of 10 June 1991 on prevention of the use of the financial system for the purpose of money laundering. OJ L 166, 28.06.1991, pp. 77–83.
(6) Directive 91/308/CEE du Conseil du 10 juin 1991 relative à la prévention de l’utilisation du système financier aux fins du blanchiment de capitaux, JO L 166, 28.06.1991, pp. 77 à 83.
(6) Richtlinie 91/308/EWG des Rates vom 10. Juni 1991 zur Verhinderung der Nutzung des Finanzsystems zum  Zwecke der Geldwäsche, ABl. L 166 vom 28.6.1991, S. 77.
(6) Directiva 91/308/CEE del Consejo, de 10 de junio de 1991, relativa a la prevención de la utilización del sistema financiero para el blanqueo de capitales. DO L 166 de 28.6.1991, p. 77.